Which are the causes of Smith-Lemli-Opitz Syndrome?

TL;DR: Smith-Lemli-Opitz syndrome is a rare genetic metabolic disorder caused by a deficiency in the enzyme 7-dehydrocholesterol reductase (DHCR7), which prevents the body from producing sufficient cholesterol. Because cholesterol is a fundamental building block for cell membranes and hormones, its deficiency during fetal development leads to the wide range of physical and developmental features observed in individuals with this syndrome.

What causes Smith-Lemli-Opitz syndrome at the genetic level?

The primary cause of Smith-Lemli-Opitz syndrome is a mutation in the DHCR7 gene, located on chromosome 11. This gene provides instructions for creating an enzyme called 7-dehydrocholesterol reductase. Think of this enzyme as the final "assembly line worker" in the body’s internal cholesterol factory. When the DHCR7 gene is mutated, the assembly line breaks down, leading to two major problems: a dangerous shortage of cholesterol and a toxic buildup of 7-dehydrocholesterol (a cholesterol precursor) in the blood and tissues. Smith-Lemli-Opitz syndrome is inherited in an autosomal recessive pattern, meaning a child must inherit one faulty copy of the gene from each parent to manifest the condition.

Are there environmental triggers for Smith-Lemli-Opitz syndrome?

Unlike some conditions that may be influenced by diet or lifestyle, Smith-Lemli-Opitz syndrome is strictly a genetic metabolic disorder. There are no known environmental triggers, such as infections, toxins, or maternal lifestyle choices, that cause the syndrome. Because the defect is present at the moment of conception within the DNA, it is not something that can be prevented or "triggered" by external factors during pregnancy. If both parents are carriers, there is a consistent 25% chance with each pregnancy that the child will be born with Smith-Lemli-Opitz syndrome.

How does the metabolic defect impact development?

Cholesterol is not just a dietary concern; it is a structural necessity for every cell in the human body. During embryonic development, cholesterol is essential for the proper signaling of the Hedgehog protein family, which acts as a "blueprint" for organ and limb formation. In Smith-Lemli-Opitz syndrome, the lack of adequate cholesterol disrupts these critical signals. This results in the hallmark features of the syndrome, which often include:

• Distinctive facial features and microcephaly (small head size).


• Structural heart defects or anomalies in the gastrointestinal tract.


• Syndactyly (webbing) of the second and third toes.


• Intellectual disability and behavioral differences.


• Genital abnormalities in males.

Is the etiology of Smith-Lemli-Opitz syndrome fully understood?

While the genetic basis of Smith-Lemli-Opitz syndrome is well-defined, researchers are still actively investigating the variability of the clinical presentation. We know that the severity of the syndrome often correlates with the specific type of mutation in the DHCR7 gene, but even individuals with the same mutation can show different levels of impairment. Ongoing research is focused on:

1. Understanding how cholesterol deficiency specifically impacts neurodevelopment and behavior.


2. Developing more effective cholesterol supplementation protocols to optimize metabolic balance.


3. Exploring how 7-dehydrocholesterol buildup might contribute to oxidative stress in tissues.

Currently, 61 individuals within the DiseaseMaps community have shared their experiences, helping researchers better map the natural history and phenotypic range of Smith-Lemli-Opitz syndrome.

Next steps

• Consult with a clinical geneticist to discuss carrier testing and family planning options.


• Work with a metabolic specialist to monitor cholesterol levels and discuss nutritional management.


• Join the DiseaseMaps community to connect with other families navigating this diagnosis.


• Visit the NIH GARD website to stay updated on the latest clinical trials and research findings.

Medical disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment; always seek the guidance of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Smith-Lemli-Opitz syndrome.


• Orphanet: 7-dehydrocholesterol reductase deficiency (Smith-Lemli-Opitz syndrome).


• Online Mendelian Inheritance in Man (OMIM): #270400 (Smith-Lemli-Opitz syndrome).


• The Smith-Lemli-Opitz Foundation: Resources for families and clinical research updates.